SLC2A1 and central nervous system cancer: Recently, 2-deoxy-D-glucose modified PEG-coated nanomaterials were created as a possible dual-targeted drug delivery strategy for boosting drug accumulation in glioma via GLUT-mediated endocytosis and enhancing blood-brain barrier passage by Glut-mediated transcytosis [69].